Literature DB >> 10816429

Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin.

K Coulonval1, F Vandeput, R C Stein, S C Kozma, F Lamy, J E Dumont.   

Abstract

The proliferation of most normal cells depends on the co-operation of several growth factors and hormones, each with a specific role, but the key events involved in the action of each necessary stimulant remain largely uncharacterized. In the present study, the pathways involved in the mechanism(s) of co-operation have been investigated in primary cultures of dog thyroid epithelial cells. In this physiologically relevant system, thyroid stimulating hormone (TSH) acting through cAMP, epidermal growth factor (EGF) and phorbol esters (such as PMA) induce DNA synthesis. Their effect requires stimulation of the insulin-like growth factor-1 (IGF-1) receptor by either IGF-1 or insulin, which are not themselves mitogenic agents. In contrast, hepatocyte growth factor (HGF) is itself fully mitogenic. The results of the study demonstrate that cAMP, EGF, HGF and PMA stimulate p70 ribosomal S6 kinase (p70 S6 kinase). However, insulin/IGF-1 also stimulate p70 S6 kinase. Thus stimulation of p70 S6 kinase might be necessary, but is certainly not sufficient, for the induction of DNA synthesis and is not specific for any stimulated pathway. In contrast, phosphatidylinositol 3-kinase (PI 3-kinase) and protein kinase B (PKB) activation by insulin and HGF is strong and sustained, whereas it is weak and transient with EGF and absent in the presence of TSH or PMA. These findings suggest that: (i) stimulation of PI 3-kinases and/or PKB is not involved in the cAMP-dependent pathways leading to thyrocyte proliferation, or in the action of PMA, (ii) the stimulation of the PI 3-kinase/PKB pathway may account for the permissive action of insulin/IGF-1 in the proliferation of these cells, and (iii) the stimulation of this pathway by HGF may explain why this agent does not require insulin or IGF-1 for its mitogenic action.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816429      PMCID: PMC1221073     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation.

Authors:  L A Serunian; K R Auger; L C Cantley
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Activation of protein kinase B (Akt/RAC-protein kinase) by cellular stress and its association with heat shock protein Hsp27.

Authors:  H Konishi; H Matsuzaki; M Tanaka; Y Takemura; S Kuroda; Y Ono; U Kikkawa
Journal:  FEBS Lett       Date:  1997-06-30       Impact factor: 4.124

3.  Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.

Authors:  L E Heasley; G L Johnson
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

4.  Mammalian TOR controls one of two kinase pathways acting upon nPKCdelta and nPKCepsilon.

Authors:  D Parekh; W Ziegler; K Yonezawa; K Hara; P J Parker
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

5.  Differential protein phosphorylation in induction of thyroid cell proliferation by thyrotropin, epidermal growth factor, or phorbol ester.

Authors:  L Contor; F Lamy; R Lecocq; P P Roger; J E Dumont
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

6.  Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP, thyroid mitogenic pathway.

Authors:  F Lamy; F Wilkin; M Baptist; J Posada; P P Roger; J E Dumont
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

7.  Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver.

Authors:  H Flotow; G Thomas
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

8.  Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells.

Authors:  M Frödin; P Peraldi; E Van Obberghen
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

9.  Identification and early activation of a Xenopus laevis p70s6k following progesterone-induced meiotic maturation.

Authors:  H A Lane; S J Morley; M Dorée; S C Kozma; G Thomas
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

10.  Demonstration of cell cycle kinetics in thyroid primary culture by immunostaining of proliferating cell nuclear antigen: differences in cyclic AMP-dependent and -independent mitogenic stimulations.

Authors:  M Baptist; J E Dumont; P P Roger
Journal:  J Cell Sci       Date:  1993-05       Impact factor: 5.285

View more
  18 in total

1.  Embryonic epithelial Pten deletion through Nkx2.1-cre leads to thyroid tumorigenesis in a strain-dependent manner.

Authors:  Saverio Bellusci; Parviz Minoo; Caterina Tiozzo; Soula Danopoulos; Maria Lavarreda-Pearce; Sheryl Baptista; Radka Varimezova; Denise Al Alam; David Warburton; Rehan Virender; Stijn De Langhe; Antonio Di Cristofano
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

2.  A novel Epac-Rap-PP2A signaling module controls cAMP-dependent Akt regulation.

Authors:  Kyoungja Hong; Liguang Lou; Sandhya Gupta; Fernando Ribeiro-Neto; Daniel L Altschuler
Journal:  J Biol Chem       Date:  2008-06-12       Impact factor: 5.157

3.  cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4.

Authors:  Sara Blancquaert; Lifu Wang; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Thurl E Harris; Pierre P Roger
Journal:  Mol Endocrinol       Date:  2010-05-19

4.  Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.

Authors:  R A Johnson; X Wang; X L Ma; S M Huong; E S Huang
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Oncogene-induced senescence and its evasion in a mouse model of thyroid neoplasia.

Authors:  Roberto Bellelli; Donata Vitagliano; Giorgia Federico; Pina Marotta; Anna Tamburrino; Paolo Salerno; Orlando Paciello; Serenella Papparella; Jeffrey A Knauf; James A Fagin; Samuel Refetoff; Giancarlo Troncone; Massimo Santoro
Journal:  Mol Cell Endocrinol       Date:  2017-06-23       Impact factor: 4.102

6.  Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.

Authors:  Maria Letizia Motti; Daniela Califano; Giancarlo Troncone; Carmela De Marco; Ilenia Migliaccio; Emiliano Palmieri; Luciano Pezzullo; Lucio Palombini; Alfredo Fusco; Giuseppe Viglietto
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells.

Authors:  Miguel A Zaballos; Bibian Garcia; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2008-01-17

8.  Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphology.

Authors:  William J Buchser; Tatiana I Slepak; Omar Gutierrez-Arenas; John L Bixby; Vance P Lemmon
Journal:  Mol Syst Biol       Date:  2010-07       Impact factor: 11.429

9.  The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.

Authors:  Maria Domenica Castellone; Valentina De Falco; Deva Magendra Rao; Roberto Bellelli; Magesh Muthu; Fulvio Basolo; Alfredo Fusco; J Silvio Gutkind; Massimo Santoro
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 10.  The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.

Authors:  Motoyasu Saji; Matthew D Ringel
Journal:  Mol Cell Endocrinol       Date:  2009-11-06       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.